Logo image of ASRT

ASSERTIO HOLDINGS INC (ASRT) Stock Price, Quote, News and Overview

NASDAQ:ASRT - Nasdaq - US04546C2052 - Common Stock - Currency: USD

0.678  0 (-0.29%)

ASRT Quote, Performance and Key Statistics

ASSERTIO HOLDINGS INC

NASDAQ:ASRT (5/30/2025, 10:44:08 AM)

0.678

0 (-0.29%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High1.8
52 Week Low0.51
Market Cap64.94M
Shares95.78M
Float93.38M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-05 2025-08-05/amc
IPO02-12 1997-02-12


ASRT short term performance overview.The bars show the price performance of ASRT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30

ASRT long term performance overview.The bars show the price performance of ASRT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ASRT is 0.678 USD. In the past month the price increased by 4.68%. In the past year, price decreased by -31.64%.

ASSERTIO HOLDINGS INC / ASRT Daily stock chart

ASRT Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 53.17 693.40B
JNJ JOHNSON & JOHNSON 15.34 370.98B
NVO NOVO-NORDISK A/S-SPONS ADR 19.67 311.08B
NVS NOVARTIS AG-SPONSORED ADR 13.8 226.48B
AZN ASTRAZENECA PLC-SPONS ADR 16.24 221.52B
MRK MERCK & CO. INC. 9.84 192.45B
PFE PFIZER INC 7.29 133.01B
SNY SANOFI-ADR 11.26 120.56B
BMY BRISTOL-MYERS SQUIBB CO 6.51 97.19B
GSK GSK PLC-SPON ADR 9.19 82.63B
ZTS ZOETIS INC 27.9 74.78B
HLN HALEON PLC-ADR 23.16 51.11B

About ASRT

Company Profile

ASRT logo image Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 58 full-time employees. The firm has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).

Company Info

ASSERTIO HOLDINGS INC

100 S. Saunders Road, Suite 300

Lake Forest ILLINOIS 60045 US

CEO: Daniel A. Peisert

Employees: 53

ASRT Company Website

ASRT Investor Relations

Phone: 12244197106

ASSERTIO HOLDINGS INC / ASRT FAQ

What is the stock price of ASSERTIO HOLDINGS INC today?

The current stock price of ASRT is 0.678 USD. The price decreased by -0.29% in the last trading session.


What is the ticker symbol for ASSERTIO HOLDINGS INC stock?

The exchange symbol of ASSERTIO HOLDINGS INC is ASRT and it is listed on the Nasdaq exchange.


On which exchange is ASRT stock listed?

ASRT stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ASSERTIO HOLDINGS INC stock?

10 analysts have analysed ASRT and the average price target is 2.87 USD. This implies a price increase of 323.12% is expected in the next year compared to the current price of 0.678. Check the ASSERTIO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ASSERTIO HOLDINGS INC worth?

ASSERTIO HOLDINGS INC (ASRT) has a market capitalization of 64.94M USD. This makes ASRT a Micro Cap stock.


How many employees does ASSERTIO HOLDINGS INC have?

ASSERTIO HOLDINGS INC (ASRT) currently has 53 employees.


What are the support and resistance levels for ASSERTIO HOLDINGS INC (ASRT) stock?

ASSERTIO HOLDINGS INC (ASRT) has a support level at 0.65 and a resistance level at 0.69. Check the full technical report for a detailed analysis of ASRT support and resistance levels.


Is ASSERTIO HOLDINGS INC (ASRT) expected to grow?

The Revenue of ASSERTIO HOLDINGS INC (ASRT) is expected to decline by -6.19% in the next year. Check the estimates tab for more information on the ASRT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ASSERTIO HOLDINGS INC (ASRT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ASSERTIO HOLDINGS INC (ASRT) stock pay dividends?

ASRT does not pay a dividend.


When does ASSERTIO HOLDINGS INC (ASRT) report earnings?

ASSERTIO HOLDINGS INC (ASRT) will report earnings on 2025-08-05, after the market close.


What is the Price/Earnings (PE) ratio of ASSERTIO HOLDINGS INC (ASRT)?

ASSERTIO HOLDINGS INC (ASRT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).


What is the Short Interest ratio of ASSERTIO HOLDINGS INC (ASRT) stock?

The outstanding short interest for ASSERTIO HOLDINGS INC (ASRT) is 5.73% of its float. Check the ownership tab for more information on the ASRT short interest.


ASRT Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to ASRT. When comparing the yearly performance of all stocks, ASRT is a bad performer in the overall market: 83.76% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ASRT Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ASRT. Both the profitability and financial health of ASRT have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ASRT Financial Highlights

Over the last trailing twelve months ASRT reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS increased by 77.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -10.69%
ROE -28.21%
Debt/Equity 0.36
Chartmill High Growth Momentum
EPS Q2Q%20%
Sales Q2Q%-18.37%
EPS 1Y (TTM)77.78%
Revenue 1Y (TTM)-16.22%

ASRT Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to ASRT. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of 2.43% and a revenue growth -6.19% for ASRT


Ownership
Inst Owners29.96%
Ins Owners1.17%
Short Float %5.73%
Short Ratio13.44
Analysts
Analysts82
Price Target2.87 (323.3%)
EPS Next Y2.43%
Revenue Next Year-6.19%